{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:35:19Z","timestamp":1777887319939,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","award":["42\/6\/6401017"],"award-info":[{"award-number":["42\/6\/6401017"]}],"id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pupt.2026.102412","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:31:27Z","timestamp":1771374687000},"page":"102412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Posaconazole attenuates arsenic trioxide toxicity and enhances safety and efficacy while reducing invasion and metastasis in non-small-cell lung cancer"],"prefix":"10.1016","volume":"92","author":[{"given":"Shima","family":"Karami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azra","family":"Rabbani-Chadegani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshid","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2026.102412_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pupt.2026.102412_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2217\/fon-2022-1212","article-title":"Plain language summary and patient perspective of the American society management of stage 3 non-small-cell lung cancer","volume":"20","author":"Jenkins","year":"2024","journal-title":"Future Oncol."},{"key":"10.1016\/j.pupt.2026.102412_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111450","article-title":"The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges","volume":"138","author":"Xie","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pupt.2026.102412_bib4","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.apsb.2022.05.024","article-title":"Gli1 promotes epithelial\u2013mesenchymal transition and metastasis of non-small cell lung carcinoma by regulating snail transcriptional activity and stability","volume":"12","author":"Lei","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.pupt.2026.102412_bib5","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.2147\/DDDT.S509769","article-title":"Artificial intelligence-driven innovations in oncology drug discovery: transforming traditional pipelines and enhancing drug design","volume":"19","author":"Albani","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.pupt.2026.102412_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrclinonc.2011.34","article-title":"High drug attrition rates-where are we going wrong?","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.pupt.2026.102412_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drudis.2015.09.017","article-title":"Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds","volume":"21","author":"Wuerth","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pupt.2026.102412_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/ijms27020817","article-title":"Emerging applications of triazole antifungal drugs","volume":"27","author":"Soldi","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pupt.2026.102412_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00056-20","article-title":"The clinically approved antifungal drug posaconazole inhibits human cytomegalovirus replication","volume":"64","author":"Mercorelli","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pupt.2026.102412_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.25259\/IJMR_569_2024","article-title":"Possibility of re-purposing antifungal drugs posaconazole & isavuconazole against promastigote form of Leishmania major","volume":"160","author":"Bhusal","year":"2024","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.pupt.2026.102412_bib11","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/acs.jmedchem.5b01718","article-title":"Repurposing the clinically efficacious antifungal agent itraconazole as an anticancer chemotherapeutic","volume":"59","author":"Pace","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pupt.2026.102412_bib12","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejmech.2018.11.056","article-title":"Development of posaconazole-based analogues as hedgehog signaling pathway inhibitors","volume":"163","author":"Teske","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pupt.2026.102412_bib13","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1158\/1535-7163.MCT-15-0729-T","article-title":"Posaconazole, a second-generation triazole antifungal drug, inhibits the hedgehog signaling pathway and progression of basal cell carcinoma","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.pupt.2026.102412_bib14","first-page":"4528","article-title":"Repurposing of posaconazole as a hedgehog\/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.pupt.2026.102412_bib15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-18-1854","article-title":"Ketoconazole and posaconazole selectively target HK2-expressing glioblastoma cells","volume":"25","author":"Agnihotri","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 2","key":"10.1016\/j.pupt.2026.102412_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.6-suppl_2-1","article-title":"Introduction: the history of arsenic trioxide in cancer therapy","volume":"6","author":"Antman","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.pupt.2026.102412_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12094-019-02054-6","article-title":"A candidate for lung cancer treatment: arsenic trioxide","volume":"21","author":"Huang","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.pupt.2026.102412_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-022-05257-y","article-title":"Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pupt.2026.102412_bib19","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/ijms21072649","article-title":"Combination of arsenic trioxide and valperoic acid efficiently inhibits grows of lung cancer cells via G2\/M-phase arrest and apoptotic cell death","volume":"21","author":"Park","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pupt.2026.102412_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s41065-024-00330-2","article-title":"Combination of arsenic trioxide and apatinib synergistically inhibits small cell lung cancer by down-regulating VEGFR2\/mTOR and Akt\/c-Myc signaling pathway via GRB10","volume":"161","author":"Yu","year":"2024","journal-title":"Hereditas"},{"key":"10.1016\/j.pupt.2026.102412_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamadermatol.2015.5473","article-title":"Effects of combined treatment with arsenic trioxide and itraconazole in patients with refractory metastatic basal cell carcinoma","volume":"152","author":"Ally","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.pupt.2026.102412_bib22","article-title":"HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition","volume":"14","author":"Ma","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.pupt.2026.102412_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pupt.2026.102412_bib24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.pupt.2026.102412_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2019.00107","article-title":"In vitro cell migration, invasion and adhesion assays: from cell imaging to data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Dev"},{"key":"10.1016\/j.pupt.2026.102412_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41418-025-01481-z","article-title":"The BCL-2 protein family: from discovery to drug development","volume":"32","author":"Croce","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pupt.2026.102412_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2022.03.011","article-title":"The impact of VEGF on cancer metastasis and systemic disease","volume":"86","author":"Yang","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.pupt.2026.102412_bib28","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/cancers14071847","article-title":"MMP9: a tough target for targeted therapy for cancer","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.pupt.2026.102412_bib29","first-page":"8","article-title":"The role of the hedgehog signaling pathway in cancer: a comprehensive review, bosn. J. Basic","volume":"18","author":"Skoda","year":"2018","journal-title":"Med. Sci."},{"key":"10.1016\/j.pupt.2026.102412_bib30","first-page":"6267","article-title":"Arsenic trioxide induces the apoptosis and decreases NF-kB expression in lymphoma cell line","volume":"16","author":"Zhong","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pupt.2026.102412_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.biopha.2018.07.019","article-title":"Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells","volume":"106","author":"Hashemi-Niasari","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.pupt.2026.102412_bib32","first-page":"670","article-title":"Restoration of MIR-349nezpression by 5-azacytidine augments Alimta induced cell death in non-small lung cancer cells by downregulation of HMGB1, A2 and Bcl-2 pathway","volume":"24","author":"Amiri","year":"2021","journal-title":"Cell J"},{"key":"10.1016\/j.pupt.2026.102412_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/1948-5956.1000379","article-title":"Evaluation of arsenic trioxide potential for lung cancer treatment: assesment of apoptosis mechanisms and oxidative damage","volume":"8","author":"Walker","year":"2016","journal-title":"J. Cancer Sci. Ther."},{"key":"10.1016\/j.pupt.2026.102412_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1158\/1535-7163.MCT-13-0065","article-title":"Synergistic anticancer activity of arsenic trioxide with erlotinib is based on inhibition of EGFR-mediated DNA double strand break repair","volume":"12","author":"Kryeziu","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.pupt.2026.102412_bib35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3892\/or.2016.4944","article-title":"Curcumin reduces the expression of surviving leading to enhancement of arsenic trioxide induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells","volume":"36","author":"Zeng","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.pupt.2026.102412_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/237543","article-title":"Indomethacin enhanced anticancer effect of arsenic trioxide in A549 cell line: involvement of apoptosis and phosphor-ERK and p38 MARK pathways","volume":"2013","author":"Mandegary","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.pupt.2026.102412_bib37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s41419-022-05257-y","article-title":"Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer","volume":"13","author":"Tang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pupt.2026.102412_bib38","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","article-title":"HMGA2 is a driver of tumor metastasis","volume":"73","author":"Morishita","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.pupt.2026.102412_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12935-025-03713-1","article-title":"Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.pupt.2026.102412_bib40","first-page":"867","article-title":"Bcl-2 overexpression sesitizers MCF-7 cells to genistein by multiple mechanisms","volume":"31","author":"Tophkhane","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.pupt.2026.102412_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-025-07513-3","article-title":"Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer","volume":"16","author":"Mart\u00edn","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.pupt.2026.102412_bib42","first-page":"8991","article-title":"Bcl-2 promotes metastasis through the epithelial to mesenchymal transition in the BCap37 medullary breast cancer cell line","volume":"15","author":"Du","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pupt.2026.102412_bib43","first-page":"105","article-title":"Hedgehog pathway and GLI1 isoforms in human cancer","volume":"13","author":"Carpenter","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.pupt.2026.102412_bib44","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/1078-0432.CCR-13-2195","article-title":"Hedgehog\u2013GLI signaling inhibition suppresses tumor growth in squamous lung cancer","volume":"20","author":"Huang","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.pupt.2026.102412_bib45","first-page":"4528","article-title":"Repurposing of posaconazole as a Hedgehog\/SMO signaling inhibitor for embryonal rhabdomyosarcoma therapy","volume":"11","author":"Sun","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.pupt.2026.102412_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pupt.2026.102412_bib47","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nature04117","article-title":"Vertebrate smoothened functions at the primary cilium","volume":"437","author":"Corbit","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2026.102412_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/cells14040269","article-title":"Hedgehog and PI3K\/Akt\/mTOR signaling pathways involvement in leukemic malignancies: crosstalk and role in cell death","volume":"14","author":"Sicurella","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.pupt.2026.102412_bib49","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41467-025-56922-7","article-title":"Phosphorylation of FOXN3 by NEK6 promotes pulmonary fibrosis through Smad signaling","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pupt.2026.102412_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/toxsci\/kfg231","article-title":"Arsenic stimulates angiogenesis and tumorigenesis in vivo","volume":"76","author":"Soucy","year":"2003","journal-title":"Toxicol. Sci."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553926000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:08:25Z","timestamp":1777608505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553926000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"alternative-id":["S1094553926000052"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102412","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Posaconazole attenuates arsenic trioxide toxicity and enhances safety and efficacy while reducing invasion and metastasis in non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2026.102412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102412"}}